Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
U.S. Food and Drug Administration granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with triple-negative breast cancer that has spread to other parts of the body. Patients must have received at least two prior therapies before taking Trodelvy.
Jaipur, 22nd April 2020: Considering the ongoing lockdown due to COVID-19, Jaipur based IIHMR University has decided to conduct GD/PI online over virtual communication app, to complete the admission process. The step was taken to support state government decision on announcement of summer vacation in public and private universities till 31st May due to Coronavirus outbreak.
Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical Companies of Johnson & Johnson and Emergent BioSolutions, Inc. to support the manufacturing of its lead investigational COVID-19 vaccine candidate. This is the first in a series of prospective global collaboration agreements designed to accelerate manufacturing of Johnson & Johnson’s COVID-19 vaccine candidate, and further the Company’s goal to supply more than one billion doses of the vaccine globally.
A study conducted in US Veteran hospital in United States found no evidence that use of hydroxychloroquine (HCQ), either with or without azithromycin, reduced the risk of mechanical ventilation or death in patients hospitalized with COVID-19.
From today itself, human trial of COVID-19 vaccine candidate will begin in the United Kingdom. This vaccine candidates are developed by research team of Oxford University. And they will receive initial funding of 22.2 million pound by UK government.
As the demand for sanitizers has increased amid coronavirus outbreak, various laboratories have started the production of sanitizers. In one such endeavour, researchers of the National Botanical Research Institute (NBRI) have developed alcohol-based herbal sanitizer. The product is developed under Council of Scientific and Industrial Research (CSIR)-Aroma Mission as per the World Health Organisation (WHO) guidelines.
The Council of Scientific and Industrial Research (CSIR) is leaving no stone unturned in the battle against novel coronavirus. Repurposing of existing drugs is one of the strategies deployed by CSIR. The Council is implementing this strategy by evaluating a an existing drug that is used for treating gram-negative sepsis patients.
This scanning electron microscope image shows SARS-CoV-2 (round gold objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S.NIAID-RML
Early treatment with the experimental antiviral drug remdesivir significantly reduced clinical disease and damage to the lungs of rhesus macaques infected with SARS-CoV-2, the coronavirus that causes COVID-19, according to National Institutes of Health scientists.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
